FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Jupiter Fund Management Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of Offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Ground Rents Income Fund plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held:        For an opening position...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary Clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LOUNGERS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Dékuple accelerates its european expansion with majority stakes in Selmore (Amsterdam) and DotControl (Rotterdam) A strategic partnership to continue building a next-generation agency model in Europe Paris, January 9, 2025 (8:00 am) – The creative agency Selmore and the digital agency DotControl are joining forces with the Dékuple Group, European leader in data marketing and communication. The integration of these two new entities into Dékuple’s multi-entrepreneur model represents a significant milestone in the Group’s external growth strategy, aimed at strengthening its footprint in Europe and expanding its expertise portfolio to better serve its international clients. This partnership further reinforces Dékuple’s commitment to becoming a leading player in communication and data marketing across Europe. Selmore, a strategic...

Chibougamau Copper-Gold Project, Canada Two diamond drill rigs about to arrive on site as part of strategy to grow the resource and test brownfield exploration targetsHIGHLIGHTS:Cygnus has secured additional ground next to its Chibougamau Copper-Gold Project, increasing its total land holding to 282km2The newly staked areas add to a highly prospective land position which has seen limited modern exploration in the past 20 years Chibougamau Copper-Gold Project has a Measured and Indicated Mineral Resource of 3.6Mt at 3.0% CuEq and an Inferred Mineral Resource of 7.2Mt at 3.8% CuEq1 The Chibougamau district is a world-class mineral terrane with strong potential for additional discovery; Historical production totals more than 945,000t of copper and 3.5Moz of gold across 16 former producing mines2 Two diamond drill rigs are set to start...

Avid Urges Stockholders to Vote FOR the Pending Transaction TODAY TUSTIN, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today posted an investor presentation in connection with its pending transaction with GHO Capital Partners LLP (“GHO”) and Ampersand Capital Partners (“Ampersand”) on its investor relations website. Highlights of the presentation include:The transaction with GHO and Ampersand delivers significant, immediate and certain cash value to Avid stockholders:The transaction presents a significant premium to the Company’s share price...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Jan. 08, 2025 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”) is pleased to announce that disinterested shareholders approved the Company’s acquisition of two affiliated home care services companies with operations in Nova Scotia at the special meeting of shareholders held today. The acquisition is a Non-Arm’s Length transaction pursuant to TSX Venture Exchange (“TSXV”) policies. More information on the acquisition is available in the Company’s Management Information Circular dated November 18, 2024 filed on SEDAR+ and the press release dated October 29, 2024. Closing of the acquisition is subject to the satisfaction of certain conditions, including the approval of the TSXV and lender...

A Key Milestone for Therapeutic Exosome Production TORONTO and HAIFA, Israel, Jan. 08, 2025 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (“NurExone” or the “Company“), a developer of exosome-based therapies for regenerative medicine, is pleased to announce that it has acquired a master cell bank from a U.S. manufacturer for an undisclosed amount (the “Acquisition”). The Acquisition marks a major step in ensuring a stable and scalable supply chain for production of exosome-based therapies for clinical needs and eventual patient treatment. The master cell bank provides a well-characterized, Good Manufacturing Practices (“GMP”) grade and exclusive source of human bone marrow mesenchymal stem cells (“MSCs”), the foundation for producing exosomes. The acquired master cell...

NEW YORK and VIENNA, Austria, Jan. 08, 2025 (GLOBE NEWSWIRE) — FORM 8 (OPD) PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFERRules 8.1 and 8.2 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: HOOKIPA Pharma Inc.(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree HOOKIPA Pharma Inc. (Offeror)(d)   Is the discloser the offeror or the offeree? Offeror(e)   Date position held:        The latest practicable date prior to the disclosure 7 January 2025(f)   In...

AMENDED DISCLOSURE – PLEASE REFER TO SECTIONS 2(a) AND 3(a) 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Learning Technologies Group Plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date...

TORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) — Kolter Capital NWH LLC (Kolter Capital), an affiliate of the Kolter Group LLC (Kolter Group) announced today that it has acquired an additional 100,000 units (Units) of Northwest Healthcare Properties Real Estate Investment Trust (the REIT) in the open market through the facilities of the Toronto Stock Exchange at an average price of CAD$4.6169 per Unit, for an aggregate purchase price of CAD$461,690 (the Acquisition). Immediately prior to completion of the Acquisition, Kolter Capital beneficially owned or exercised control or direction over 24,663,400 Units, representing approximately 9.99% of the issued and outstanding Units. Upon completion of the Acquisition, Kolter Capital now beneficially owns or exercises control or direction over 24,763,400 Units, representing approximately 10.03%...